Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707616 · ClinicalTrials.gov registry record
Common Genetic Variation and Type 2 Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 190
- Enrollment target
NCT00707616: Completed study, sponsored by Mayo Clinic.
NCT00707616 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 190 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707616 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 190 participants
- Enrollment target
Study Summary
Type 2 diabetes is a common metabolic disorder arising from a complex interaction between genetic predisposition and the environment. The development of this disorder is preceded by impaired glucose tolerance and elevated fasting glucose which also carry adverse cardiovascular risk. To date a few common genetic variants have been reliably associated with predisposition to type 2 diabetes. However, it is uncertain how these genes interact to alter insulin secretion and insulin action prior to the development of type 2 diabetes. We propose to utilize an established population-based cohort to determine how common genetic variants associated with type 2 diabetes alter the response to an oral glucose challenge in people without overt type 2 diabetes. This will enable us to understand how common variants alone or in combination alter whole-body glucose physiology and predispose to type 2 diabetes.
Primary Outcome
Measured by 7-sample, 2Hr OGTT
Interventions
- OTHER Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2006-03 |
| Est. Completion | 2012-12 |
What the finished NCT00707616 record still lists
NCT00707616 is an observational study that tracks outcomes without assigning an intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT00707616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00707616 about?
NCT00707616 is a clinical study titled "Common Genetic Variation and Type 2 Diabetes". Type 2 diabetes is a common metabolic disorder arising from a complex interaction between genetic predisposition and the environment. The development of this disorder is preceded by impaired glucose tolerance and elevated fasting glucose which also carry adverse cardiovascular risk. To date a few co...
What is the current status of trial NCT00707616?
This trial is currently completed. The enrollment target is 190 participants. The study started on 2006-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00707616?
The interventions under investigation include: Oral glucose tolerance test (OTHER).
Who is sponsoring clinical trial NCT00707616?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia